X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2102) 2102
Publication (182) 182
Book Review (37) 37
Book Chapter (15) 15
Conference Proceeding (4) 4
Book / eBook (3) 3
Magazine Article (3) 3
Government Document (1) 1
Streaming Video (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (1213) 1213
parkinson's disease (952) 952
humans (861) 861
index medicus (850) 850
male (830) 830
levodopa (804) 804
neurosciences (779) 779
rats (630) 630
parkinson disease - drug therapy (573) 573
parkinsons-disease (510) 510
l-dopa (502) 502
levodopa - pharmacology (478) 478
dopamine (452) 452
female (448) 448
clinical neurology (428) 428
pharmacology & pharmacy (416) 416
levodopa - therapeutic use (404) 404
dopa (335) 335
disease models, animal (327) 327
antiparkinson agents - therapeutic use (321) 321
mice (302) 302
rats, sprague-dawley (292) 292
levodopa - toxicity (280) 280
dopamine - metabolism (276) 276
levodopa - adverse effects (259) 259
movement disorders (258) 258
neurons (246) 246
oxidopamine - toxicity (242) 242
neurology (241) 241
dose-response relationship, drug (229) 229
dyskinesia (220) 220
brain (205) 205
middle aged (205) 205
parkinsons disease (204) 204
oxidative stress (200) 200
antiparkinson agents - adverse effects (197) 197
levodopa - administration & dosage (196) 196
basal ganglia (194) 194
phenols (192) 192
aged (189) 189
corpus striatum - drug effects (185) 185
motor activity - drug effects (183) 183
time factors (180) 180
analysis (177) 177
neurodegenerative diseases (170) 170
antiparkinson agents - pharmacology (168) 168
substantia-nigra (166) 166
corpus striatum - metabolism (164) 164
parkinson’s disease (163) 163
parkinson disease - physiopathology (162) 162
neurons - drug effects (160) 160
levodopa-induced dyskinesia (155) 155
6-hydroxydopamine (154) 154
biochemistry & molecular biology (153) 153
double-blind (153) 153
parkinsonian disorders - drug therapy (145) 145
motor fluctuations (143) 143
levodopa - metabolism (136) 136
striatum (132) 132
tyrosine 3-monooxygenase - metabolism (130) 130
rats, wistar (129) 129
parkinson disease - metabolism (128) 128
neuroprotection (123) 123
neurotoxicity (123) 123
toxicity (123) 123
levodopa-induced dyskinesias (117) 117
mice, inbred c57bl (115) 115
antiparkinson agents - toxicity (113) 113
antiparkinson agents - administration & dosage (112) 112
dopamine agents - pharmacology (112) 112
dopa-induced dyskinesia (107) 107
drug therapy, combination (106) 106
drug therapy (105) 105
behavior, animal - drug effects (104) 104
disease (104) 104
drug interactions (104) 104
dyskinesia, drug-induced - etiology (103) 103
adult (102) 102
dihydroxyphenylalanine (102) 102
brain - metabolism (101) 101
parkinson disease, secondary - chemically induced (101) 101
dyskinesia, drug-induced - drug therapy (100) 100
parkinson disease - etiology (100) 100
nervous system diseases (99) 99
brain - drug effects (98) 98
mptp (98) 98
substantia nigra - drug effects (98) 98
article (95) 95
psychiatry (95) 95
neurons - metabolism (92) 92
dopaminergic-neurons (91) 91
dyskinesia, drug-induced - metabolism (89) 89
pc12 cells (88) 88
dyskinesia, drug-induced - physiopathology (87) 87
parkinson disease (87) 87
therapy (85) 85
dopamine receptors (84) 84
adrenergic agents - toxicity (83) 83
cell survival - drug effects (83) 83
parkinson disease - pathology (83) 83
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2095) 2095
Russian (5) 5
Spanish (5) 5
French (4) 4
Chinese (3) 3
Japanese (2) 2
Polish (2) 2
Dutch (1) 1
German (1) 1
Hungarian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Drug Safety, ISSN 0114-5916, 7/2016, Volume 39, Issue 7, pp. 661 - 674
Journal Article
Journal Article
Neuroscience, ISSN 0306-4522, 09/2017, Volume 358, pp. 336 - 348
Journal Article
by Agid, Y
Neurology, ISSN 0028-3878, 1998, Volume 50, Issue 4, pp. 858 - 863
Whether a drug such as levodopa, which is prescribed for long periods, may be toxic is a legitimate and even indispensable question. The problem is no... 
LONG-TERM | MORTALITY | MOTOR FLUCTUATIONS | MESENCEPHALIC CELL-CULTURES | L-DOPA | RATS | 6-HYDROXYDOPAMINE | DOPAMINERGIC-NEURONS | CLINICAL NEUROLOGY | PARKINSONS-DISEASE | PROTECTS | Dopamine Agents - toxicity | Levodopa - toxicity | Parkinson Disease - drug therapy | Animals | Humans
Journal Article
Nanoscale Research Letters, ISSN 1931-7573, 2015, Volume 10, Issue 1, pp. 105 - 105
Layered double hydroxide (LDH) is an inorganic-organic nano-layered material that harbours drug between its two-layered sheets, forming a sandwich-like... 
Layered hydroxide | Nanocomposite | Levodopa | Acute toxicity | PHYSICS, APPLIED | DRUG-DELIVERY | MATERIALS SCIENCE, MULTIDISCIPLINARY | NANOSCIENCE & NANOTECHNOLOGY | BLOOD-BRAIN-BARRIER | NANOPARTICLES | TRANSPORT | IN-VIVO | DISEASE | Drugs | Drug delivery systems | Hydroxides | Analysis | Resveratrol | Chemical properties | Dopa | Vehicles
Journal Article
Journal Article
Experimental Neurology, ISSN 0014-4886, 09/2015, Volume 271, Issue May 30, pp. 335 - 350
Journal Article